Skip to main content
Fig. 4 | BMC Health Services Research

Fig. 4

From: Clinicians’ attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza

Fig. 4

How often do you prescribe neuraminidase inhibitors in each of the following groups of hospitalised adults when influenza infection is confirmed (i.e. influenza test result is positive)?

Legend: PNA – pneumonia, CLD - Exacerbation of chronic lung disease (e.g. COPD, asthma), LRTI – non-pneumonic lower respiratory tract infection, Other – other acute medical illnesses e.g. cardiac failure

Back to article page